New Delhi: The Institute of Biotechnology Research and Innovation Council (iBRIC), a subset of Department of Biotechnology, Government of India organised the second THSTI Advanced Course in Vaccinology (TiVaC) in collaboration with Coalition for Epidemic Preparedness Innovations (CEPI).
The six day course is organised at iBRIC-THSTI Faridabad campus from May 27th to June 1st and aims to provide a comprehensive overview on the concepts and steps involved in the design, development and commercialization of vaccines to both Indian and International participants.
The vaccine development programme will cover basic biology and immunology of vaccine development; pre-clinical research; clinical trial design including statistical processes; regulatory clearances and procedures; manufacturing and quality compliance.
Covering varied aspects of the vaccine market the programme will focus on: basic biology and immunology of vaccine development; pre-clinical research; clinical trial design including statistical processes; regulatory clearances & procedures; manufacturing and quality compliance.
Expressing his views at the inauguration of the course Dr G Karthikeyan, Executive Director, the iBRIC-THSTI, stressed the need for training in advanced fields of research and the need for training programmes to enhance both institutional and national capacity in this area.
“The iBRIC-THSTI would consider the possibility of setting up more short term intense training programmes for national and international researchers,” Dr Karthikeyan added.
Training in principles of vaccinology and immunology is a crucial aspect of appropriating global leadership in vaccine development. Keeping in view the same, the iBRIC-THSTI has opened the vaccinology course to young researchers and professionals from Low and Middle Income Countries (LMICs).
